JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB63913

Anti-HIV1 p24 antibody

Be the first to review this product! Submit a review

|

(26 Publications)

Rabbit Polyclonal POL antibody. Suitable for ELISA, WB and reacts with Human immunodeficiency virus samples. Cited in 26 publications.

View Alternative Names

Gag-Pol polyprotein, Pr160Gag-Pol, gag-pol

1 Images
Western blot - Anti-HIV1 p24 antibody (AB63913)
  • WB

Unknown

Western blot - Anti-HIV1 p24 antibody (AB63913)

Bands at 41 and 55 kDa are also observed corresponding to HIV-p24 precursor proteins p41 and p55.

All lanes:

Western blot - Anti-HIV1 p24 antibody (ab63913) at 1/2500 dilution

Lane 1:

Extract of MT4 cells

Lane 2:

Extract of MT4 cells infected with HIV-1 (LAI strain)

Predicted band size: 56 kDa

Observed band size: 24 kDa

false

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human immunodeficiency virus

Applications

WB, ELISA

applications

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "ELISA" : {"fullname" : "ELISA", "shortname":"ELISA"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human immunodeficiency virus": { "ELISA-species-checked": "guaranteed", "ELISA-species-dilution-info": "", "ELISA-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/2500", "WB-species-notes": "<p></p>" } } }

Properties and storage information

Form
Liquid
Purity
Whole antiserum
Storage buffer
pH: 6 - 8.5 Preservative: 0.09% Sodium azide Constituents: Whole serum
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

HIV1 p24 also known as HIV p24 protein is a core protein of the Human Immunodeficiency Virus type 1 (HIV-1). The p24 protein has a molecular weight of about 24 kDa. HIV1 p24 comprises part of the viral capsid which encases the viral RNA genome. This protein is prominently expressed during the early stages of HIV infection. The presence of HIV1 p24 is commonly detected through various laboratory techniques including the use of p24 ELISA kits.
Biological function summary

HIV1 p24 plays an important role in the viral life cycle. It assists in the formation and stability of the viral capsid which is critical for maintaining the integrity of the viral core. HIV p24 is not a lone actor; it is part of the structural framework and interacts with other viral proteins to facilitate the viral assembly and maturation processes. The detection of HIV1 p24 is a marker for viral replication and infection stage.

Pathways

The function of HIV1 p24 aligns significantly within the HIV replication pathway and the host’s immune response pathway. HIV p24 is intrinsically tied to processes of viral assembly alongside proteins like Gag and Pol coordinating to ensure successful viral replication. Furthermore the immune system recognizes the HIV1 p24 protein thereby integrating it into the host immune response which is important in disease progression and for diagnostic purposes like in the HIV ELISA assay.

HIV1 p24 is integrally connected to HIV/AIDS a disorder that profoundly affects the immune system. The presence of HIV p24 in the bloodstream is an early marker of infection and is frequently monitored to track the disease's progression. Alterations in the levels of p24 protein relate to the efficiency of therapeutic interventions. The study of HIV1 p24 also brings focus on its interaction with the CD4 receptor which is pivotal in the viral entry process further linking various stages of the HIV infection cycle to potential therapeutic targets.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Gag-Pol polyprotein. Mediates, with Gag polyprotein, the essential events in virion assembly, including binding the plasma membrane, making the protein-protein interactions necessary to create spherical particles, recruiting the viral Env proteins, and packaging the genomic RNA via direct interactions with the RNA packaging sequence (Psi). Gag-Pol polyprotein may regulate its own translation, by the binding genomic RNA in the 5'-UTR. At low concentration, the polyprotein would promote translation, whereas at high concentration, the polyprotein would encapsidate genomic RNA and then shut off translation.. Matrix protein p17. Targets the polyprotein to the plasma membrane via a multipartite membrane-binding signal, that includes its myristoylated N-terminus (By similarity). Matrix protein is part of the pre-integration complex. Implicated in the release from host cell mediated by Vpu. Binds to RNA (By similarity).. Capsid protein p24. Forms the conical core that encapsulates the genomic RNA-nucleocapsid complex in the virion (PubMed : 8648689). Most core are conical, with only 7% tubular. The core is constituted by capsid protein hexamer subunits. The core is disassembled soon after virion entry (PubMed : 12660176). Host restriction factors such as monkey TRIM5-alpha or TRIMCyp bind retroviral capsids and cause premature capsid disassembly, leading to blocks in reverse transcription. Capsid restriction by TRIM5 is one of the factors which restricts HIV-1 to the human species (PubMed : 23785198). Host PIN1 apparently facilitates the virion uncoating (By similarity). On the other hand, interactions with PDZD8 or CYPA stabilize the capsid (PubMed : 24554657).. Nucleocapsid protein p7. Encapsulates and protects viral dimeric unspliced genomic RNA (gRNA). Binds these RNAs through its zinc fingers. Acts as a nucleic acid chaperone which is involved in rearangement of nucleic acid secondary structure during gRNA retrotranscription. Also facilitates template switch leading to recombination. As part of the polyprotein, participates in gRNA dimerization, packaging, tRNA incorporation and virion assembly.. Protease. Aspartyl protease that mediates proteolytic cleavages of Gag and Gag-Pol polyproteins during or shortly after the release of the virion from the plasma membrane (PubMed : 11932404, PubMed : 9573231). Cleavages take place as an ordered, step-wise cascade to yield mature proteins (PubMed : 11932404, PubMed : 9573231). This process is called maturation (PubMed : 11932404, PubMed : 9573231). Displays maximal activity during the budding process just prior to particle release from the cell (PubMed : 11932404, PubMed : 9573231). Also cleaves Nef and Vif, probably concomitantly with viral structural proteins on maturation of virus particles (PubMed : 7835426). Hydrolyzes host EIF4GI and PABP1 in order to shut off the capped cellular mRNA translation. The resulting inhibition of cellular protein synthesis serves to ensure maximal viral gene expression and to evade host immune response (PubMed : 12660176, PubMed : 19914170). Also mediates cleavage of host YTHDF3 (PubMed : 32053707). Mediates cleavage of host CARD8, thereby activating the CARD8 inflammasome, leading to the clearance of latent HIV-1 in patient CD4(+) T-cells after viral reactivation; in contrast, HIV-1 can evade CARD8-sensing when its protease remains inactive in infected cells prior to viral budding (PubMed : 33542150).. Reverse transcriptase/ribonuclease H. Multifunctional enzyme that converts the viral RNA genome into dsDNA in the cytoplasm, shortly after virus entry into the cell. This enzyme displays a DNA polymerase activity that can copy either DNA or RNA templates, and a ribonuclease H (RNase H) activity that cleaves the RNA strand of RNA-DNA heteroduplexes in a partially processive 3' to 5' endonucleasic mode. Conversion of viral genomic RNA into dsDNA requires many steps. A tRNA(3)-Lys binds to the primer-binding site (PBS) situated at the 5'-end of the viral RNA. RT uses the 3' end of the tRNA primer to perform a short round of RNA-dependent minus-strand DNA synthesis. The reading proceeds through the U5 region and ends after the repeated (R) region which is present at both ends of viral RNA. The portion of the RNA-DNA heteroduplex is digested by the RNase H, resulting in a ssDNA product attached to the tRNA primer. This ssDNA/tRNA hybridizes with the identical R region situated at the 3' end of viral RNA. This template exchange, known as minus-strand DNA strong stop transfer, can be either intra- or intermolecular. RT uses the 3' end of this newly synthesized short ssDNA to perform the RNA-dependent minus-strand DNA synthesis of the whole template. RNase H digests the RNA template except for two polypurine tracts (PPTs) situated at the 5'-end and near the center of the genome. It is not clear if both polymerase and RNase H activities are simultaneous. RNase H probably can proceed both in a polymerase-dependent (RNA cut into small fragments by the same RT performing DNA synthesis) and a polymerase-independent mode (cleavage of remaining RNA fragments by free RTs). Secondly, RT performs DNA-directed plus-strand DNA synthesis using the PPTs that have not been removed by RNase H as primers. PPTs and tRNA primers are then removed by RNase H. The 3' and 5' ssDNA PBS regions hybridize to form a circular dsDNA intermediate. Strand displacement synthesis by RT to the PBS and PPT ends produces a blunt ended, linear dsDNA copy of the viral genome that includes long terminal repeats (LTRs) at both ends.. Integrase. Catalyzes viral DNA integration into the host chromosome, by performing a series of DNA cutting and joining reactions. This enzyme activity takes place after virion entry into a cell and reverse transcription of the RNA genome in dsDNA. The first step in the integration process is 3' processing. This step requires a complex comprising the viral genome, matrix protein, Vpr and integrase. This complex is called the pre-integration complex (PIC). The integrase protein removes 2 nucleotides from each 3' end of the viral DNA, leaving recessed CA OH's at the 3' ends. In the second step, the PIC enters cell nucleus. This process is mediated through integrase and Vpr proteins, and allows the virus to infect a non dividing cell. This ability to enter the nucleus is specific of lentiviruses, other retroviruses cannot and rely on cell division to access cell chromosomes. In the third step, termed strand transfer, the integrase protein joins the previously processed 3' ends to the 5' ends of strands of target cellular DNA at the site of integration. The 5'-ends are produced by integrase-catalyzed staggered cuts, 5 bp apart. A Y-shaped, gapped, recombination intermediate results, with the 5'-ends of the viral DNA strands and the 3' ends of target DNA strands remaining unjoined, flanking a gap of 5 bp. The last step is viral DNA integration into host chromosome. This involves host DNA repair synthesis in which the 5 bp gaps between the unjoined strands are filled in and then ligated. Since this process occurs at both cuts flanking the HIV genome, a 5 bp duplication of host DNA is produced at the ends of HIV-1 integration. Alternatively, Integrase may catalyze the excision of viral DNA just after strand transfer, this is termed disintegration.
See full target information gag-pol

Publications (26)

Recent publications for all applications. Explore the full list and refine your search

Nature communications 16:2998 PubMed40148322

2025

Keratin-72 restricts HIV-1 infection in resting CD4 T cells by sequestering capsids in intermediate filaments.

Applications

Unspecified application

Species

Unspecified reactive species

Yang He,Meng Xu,Jiayue Ouyang,Li Zhao,Tiankui Ma,Xiaowei Zhang,Ruolin Wang,Hong Shang,Guoxin Liang

ACS nano 18:26568-26584 PubMed39306763

2024

Simultaneous Protein and RNA Analysis in Single Extracellular Vesicles, Including Viruses.

Applications

Unspecified application

Species

Unspecified reactive species

Zach Troyer,Olesia Gololobova,Aakash Koppula,Zhaohao Liao,Felix Horns,Michael B Elowitz,Juan Pablo Tosar,Mona Batish,Kenneth W Witwer

Biochemistry 62:2115-2127 PubMed37341186

2023

Irreversible Inactivation of SARS-CoV-2 by Lectin Engagement with Two Glycan Clusters on the Spike Protein.

Applications

Unspecified application

Species

Unspecified reactive species

Aakansha Nangarlia,Farah Fazloon Hassen,Gabriela Canziani,Praneeta Bandi,Choya Talukder,Fengwen Zhang,Douglas Krauth,Ebony N Gary,David B Weiner,Paul Bieniasz,Sonia Navas-Martin,Barry R O'Keefe,Charles G Ang,Irwin Chaiken

Proceedings of the National Academy of Sciences of the United States of America 120:e2212991120 PubMed36638209

2023

Urokinase plasminogen activator surface receptor restricts HIV-1 replication by blocking virion release from the cell membrane.

Applications

Unspecified application

Species

Unspecified reactive species

Hailin Pang,Jiayue Ouyang,Zengwen Yang,Hong Shang,Guoxin Liang

PLoS pathogens 18:e1010673 PubMed35788752

2022

Active PD-L1 incorporation within HIV virions functionally impairs T follicular helper cells.

Applications

Unspecified application

Species

Unspecified reactive species

Olivia Munoz,Riddhima Banga,Rachel Schelling,Francesco Andrea Procopio,Andrea Mastrangelo,Pauline Nortier,Khalid Ohmiti,Jean Daraspe,Matthias Cavassini,Craig Fenwick,Laurent Perez,Matthieu Perreau

Proceedings of the National Academy of Sciences of the United States of America 119: PubMed34987100

2022

Neuropilin-1, a myeloid cell-specific protein, is an inhibitor of HIV-1 infectivity.

Applications

Unspecified application

Species

Unspecified reactive species

Shumei Wang,Li Zhao,Xiaowei Zhang,Jingjing Zhang,Hong Shang,Guoxin Liang

Journal of virology 95:e0081621 PubMed34133900

2021

TLR1/2 Agonist Enhances Reversal of HIV-1 Latency and Promotes NK Cell-Induced Suppression of HIV-1-Infected Autologous CD4 T Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Siqin Duan,Xinfeng Xu,Jinshen Wang,Liwen Huang,Jie Peng,Tao Yu,Yang Zhou,Kui Cheng,Shuwen Liu

Nature communications 12:3691 PubMed34140527

2021

Vpr counteracts the restriction of LAPTM5 to promote HIV-1 infection in macrophages.

Applications

Unspecified application

Species

Unspecified reactive species

Li Zhao,Shumei Wang,Meng Xu,Yang He,Xiaowei Zhang,Ying Xiong,Hong Sun,Haibo Ding,Wenqing Geng,Hong Shang,Guoxin Liang

Journal of medicinal chemistry 64:3747-3766 PubMed33750123

2021

Rapid Optimization of the Metabolic Stability of a Human Immunodeficiency Virus Type-1 Capsid Inhibitor Using a Multistep Computational Workflow.

Applications

Unspecified application

Species

Unspecified reactive species

Megan E Meuser,Poli Adi Narayana Reddy,Alexej Dick,Jean Marc Maurancy,Joseph M Salvino,Simon Cocklin

Journal of medicinal chemistry 63:4790-4810 PubMed32298111

2020

Design, Synthesis, and Mechanism Study of Benzenesulfonamide-Containing Phenylalanine Derivatives as Novel HIV-1 Capsid Inhibitors with Improved Antiviral Activities.

Applications

Unspecified application

Species

Unspecified reactive species

Lin Sun,Alexej Dick,Megan E Meuser,Tianguang Huang,Waleed A Zalloum,Chin-Ho Chen,Srinivasulu Cherukupalli,Shujing Xu,Xiao Ding,Ping Gao,Dongwei Kang,Erik De Clercq,Christophe Pannecouque,Simon Cocklin,Kuo-Hsiung Lee,Xinyong Liu,Peng Zhan
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com